Comprehensive supply chain solutions for the Life Sciences
CryoPortal Login
  • English
    • Español (Spanish)
    • Français (French)
    • 日本語 (Japanese)
    • 简体中文 (Chinese)
Cryoport Systems logo
  • Industry Expertise
    • Cell Therapy
    • Gene Therapy
    • Biologics
    • Support by Development Phase
      • Pre-Clinical Programs
      • Phase I Clinical Programs
      • Phase II Clinical Programs
      • Phase III Clinical Programs
      • Commercial Programs
    • Reproductive Medicine
      • Intended Parents
      • Clinics
    • Animal Health
      • Animal Pharmaceuticals
      • Livestock Management
      • Veterinary Care
  • Trusted Solutions
    • Shipping Systems
      • Cryogenic (below -150°C) Shipping Systems
        • Cryoport Express® Cryogenic Standard Shipping System
        • Cryoport Express® Cryogenic Combo Shipping System
        • Cryoport Express® Cryogenic HV3 Shipping System
        • Cryomax® Cryogenic Shipping System
      • Ultra Cold (-60 to -80°C) Shipping Systems
        • Cryoport Elite® Ultra Cold
      • Refrigerated (2 to 8°C) and CRT (15 to 25°C) Shipping Systems
        • Cryoport Express® C3™ Shipping System
      • Cryoport Accessories
        • Cryoport Safepak® System
    • Transportation
      • Cryoshuttle®
    • BioServices
      • Biostorage Solutions
      • Kit Production
      • Secondary Packaging and Labelling
      • Clinical Sample Management
      • Regulatory & QP Services
    • Consulting Services
      • Shipping Risk Assessment and Shipping Lane Qualification
      • Shipping System and Packaging Performance Qualification
      • Custom Packaging and Accessory Development
    • IntegriCell® Cryopreservation
  • Technology
    • Cryoportal®
    • Veri-Clean®
    • Chain of Compliance®
    • Tec4med
    • Custom Packaging and Accessory Development
  • About Us
    • Our People
    • Management
    • Quality
    • Careers
    • Cryoport’s Family of Companies
  • Resources
    • Events
    • Supply Chain Blog
    • Company News & Articles
    • Brochures and Spec Sheets
    • Instructions
    • White Papers and Case Studies
    • Videos/Webinars
    • Reference Materials
      • Cryoportal® 2 Training Materials
      • Validation Package Request
      • Data Station Direction & Validation
      • Quality Change Notification Request
      • Certifications
      • Smartpak II™ Airline Authorizations
  • Contact Us
    • Request a Quote
    • Locations
  • Investor Relations
CryoPortal Login
Request Info
Request a Quote
Request a Quote
Request Info Request a Quote

Supply Chain Archives

Accelerate Your Trials Without Losing Control With an End-to-End Supply Chain Model
Managing the Cold Chain
04/21/2026

Accelerate Your Trials Without Losing Control With an End-to-End Supply Chain Model

As programs shift from Phase I to Phase II, the workload starts to overlap in new ways. Sample volumes increase as more sites operate in parallel, and activities that once occurred in sequence now run at the same time. The work itself is largely the same, but keeping it coordinated requires more time and attention.

Read More

Read More
Validated Shipping Systems are the Foundation of Risk-Mitigated Animal Health Logistics
Animal Health
04/21/2026

Validated Shipping Systems are the Foundation of Risk-Mitigated Animal Health Logistics

Animal health logistics are entering a phase where variability is no longer tolerable. Vaccines, biologics, reproductive materials, and advanced therapies are sensitive to critical parameters like temperature and handling conditions, and as regulatory expectations continue to move toward tighter controls and clearer documentation, shipping has become so much more than a support function.

Read More

Read More
Where Innovation Is Moving the Advanced Therapies Supply Chain: A Q&A with Alison Pritchard
Managing the Cold Chain
04/09/2026

Where Innovation Is Moving the Advanced Therapies Supply Chain: A Q&A with Alison Pritchard

Following the Advanced Therapies Congress 2026, where Alison Pritchard delivered a keynote and participated in a panel discussion, she sat down for a brief conversation to expand on some of the themes that emerged during this year’s event. Alison’s perspective captures a few of the ideas she believes are shaping the next phase of supply chain design in advanced therapies.

Read More

Read More
The Visibility and Traceability Animal Health Programs Need
Animal Health
03/19/2026

The Visibility and Traceability Animal Health Programs Need

Temperature-sensitive materials now move through animal health programs in far greater volumes, and that shift has raised the bar for how their transit needs to be documented. Teams responsible for oversight want documentation that reflects actual handling conditions from origin to delivery, with enough detail to support a clear assessment of risk. While the regulatory environment for animal health lags behind that for human health, programs are increasingly expected to provide records that reflect the actual conditions and custody of the material throughout transit.

Read More

Read More
Biosecurity in Transit: How Veri-Clean® Protects Vaccines and Reproductive Materials
Animal Health
02/20/2026

Biosecurity in Transit: How Veri-Clean® Protects Vaccines and Reproductive Materials

The outcomes of animal health vaccine programs, veterinary networks, and breeding operations depend on precision. Within these facilities, biosecurity protocols guide every action, and teams continuously monitor conditions. Everyone understands that dosage potency and genetic integrity hang in the balance, so nothing is left to chance. But the moment materials leave those walls, the equation changes.

Read More

Read More
Build Standardization Where It Matters Most: Turning Stability into True Consistency
Managing the Cold Chain
02/18/2026

Build Standardization Where It Matters Most: Turning Stability into True Consistency

There is a quiet assumption that many early-phase teams make when they transition to cryopreserved starting material... that freezing alone will solve their variability problem. On the surface, it feels true. Cryopreservation stops the clock, stabilizes the cells, and removes the minute-to-minute fragility of fresh material. But the stability that teams expect isn’t guaranteed by freezing itself, it’s created by how the freezing is done. And in practice, this is where programs often get surprised.

Read More

Read More
Preparing Animal Health Logistics for a More Regulated Future
Animal Health
01/27/2026

Preparing Animal Health Logistics for a More Regulated Future

Bringing an advanced animal health therapy to market today demands the same operational discipline once reserved for human biopharma. Yet animal health developers are still operating in an environment that lacks the robust logistics standards that govern human therapeutic transport. As programs expand across sites and geographies, the lack of shared and consistent handling expectations creates variability that becomes one of the biggest operational barriers to scale.

Read More

Read More
Celebrating Innovation at the Cryoport Systems Grand Opening in Louvres, France
Managing the Cold Chain
12/22/2025

Celebrating Innovation at the Cryoport Systems Grand Opening in Louvres, France

Cryoport Systems recently opened the doors of its newest Global Supply Chain Center (GSCC) in Louvres, France, marking a major step forward in how cell and gene therapies move safely and compliantly across Europe and the world. Strategically located just outside Paris and minutes from Charles de Gaulle Airport (CDG), this GSCC strengthens our integrated network and brings critical capabilities closer to sponsors, CROs, CDMOs, and clinical sites throughout the region, and strengthens our support of regional animal health and reproductive medicine organizations. 

Read More

Read More
Expert Q&A: Is Standardization the Bottleneck or Breakthrough to Building Scalable and Cost-Effective CGT Programs?
Industry Insights
12/19/2025

Expert Q&A: Is Standardization the Bottleneck or Breakthrough to Building Scalable and Cost-Effective CGT Programs?

Cell and gene therapy (CGT) companies are under constant pressure to do more while hitting milestones earlier. Demonstrate manufacturability. Ensure regulatory readiness. Design for scalability and patient access. And do all of this with more constrained resources and increasingly aggressive timelines. Building on our recent panel discussion, we gathered extended perspectives from Dr. Don Fink (Dark Horse Consulting Group), Audrey Greenberg (Mayo Venture Partners), Dr. Dominic Clarke (Cryoport Systems), and Kurtis Carlisle (Cabaletta Bio).  

Read More

Read More
Load More

Categories

  • All (63)
  • Industry Insights (24)
  • Managing the Cold Chain (55)
  • Navigating Logistics (27)
  • Patient Access and Awareness (8)

Tags

  • Asia
  • ATMPs
  • Biologics
  • BioServices
  • Biostorage
  • CDMO
  • CDMOs
  • Cell Therapy
  • Clinical Trials
  • Cold Chain Management
  • Commercialization
  • CROs
  • Cryopreservation
  • Europe
  • Fragmentation
  • Gene Therapy
  • Global Logistics Tracking
  • Global Supply Chain Management
  • International Shipping
  • North America
  • Risk Mitigation
  • Standards and Compliance
  • Supply Chain Management

Subscribe to our newsletter

Never miss another update! Join our mailing list for all the latest news, events, and announcements.

  • Clinical Trial icon Trusted with 760 clinical trials
  • Approved therapies icons Supporting 20 approved therapies
  • Quality icon Robust quality standards
  • Client service icon 24/7/365 support team
  • About Us
  • Industries
  • Solutions
  • Resources
  • Technology & Innovation
  • Contact Us
  • About Us
  • Industries
  • Solutions
  • Resources
  • Technology & Innovation
  • Contact Us
Cryoport Systems logo
  • Privacy Policy
  • Terms of Use
  • Careers
Request a Quote
  • youtube
  • twitter
  • linkedin
Cryoport Systems logo

© 2024 Cryoport Systems, LLC. All rights reserved.
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

  • youtube
  • twitter
  • linkedin